Resources

Michael Abramoff, MD, PhD - Founder and Executive Chairman of Digital Diagnostics, John Bertrand - CEO and Co-Founder , Juli Goldstein - VP of Government Affairs & Market Access

How AI Can Drive Improvements in Access, Equity and Value-Based Care

Speaking Engagements

View All Events

Newsroom

View All Newsroom Posts

December 12, 2024

Keep an eye on diabetic retinopathy

News

December 11, 2024

White Paper: Autonomous AI Prevents Blindness by Increasing Eye Exam for Diabetes Access for So-Cal Patients

Insights

November 26, 2024

Digital Diagnostics and Google Cloud Collaborate to Combat Diabetic Retinopathy in the Kingdom of Saudi Arabia

Press Releases

View All Newsroom Posts

Have Questions that Need Answers?

Check out these answers to our most frequently asked questions and see if they help.

View All FAQs

Papers / Trials

Effectiveness of artificial intelligence screening in preventing vision loss from diabetes: a policy model

Implementation of Point-of-Care Diabetic Retinal Exams Using Autonomous AI in a Federally Qualified Health Center

Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations

Digital Media

Revolutionizing the Eye Exam for Diabetes with LumineticsCore™

The Patient Perspective: Changing Lives with LumineticsCore’s Diagnostic AI

Digital Diagnostics Mission: Transforming Global Healthcare with AI

Events

AI Regulation and Implementation in Ophthalmology – FDA Submission Experience for AI in Diabetic Retinopathy

American Academy of Optometry (AAO)

How AI Can Drive Improvements in Access, Equity and Value-Based Care

Newsroom

Keep an eye on diabetic retinopathy

White Paper: Autonomous AI Prevents Blindness by Increasing Eye Exam for Diabetes Access for So-Cal Patients

Digital Diagnostics and Google Cloud Collaborate to Combat Diabetic Retinopathy in the Kingdom of Saudi Arabia

Have Questions that Need Answers?

Clinical Research Interest Form